| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $2.57B | +33.4% |
| Cost of Revenue | $1.46B | +22.5% |
| Gross Profit | $1.12B | +51.1% |
| R&D Expense | $169.7M | +6.2% |
| SG&A Expense | $111.5M | +37.7% |
| Operating Income | $836.3M | +67.6% |
| Pre-tax Income | $805.7M | +90.1% |
| Income Tax | $93.7M | +26.9% |
| Net Income | $711.9M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $149.7M | +18.5% |
| Accounts Receivable | $244.6M | +44.6% |
| Inventory | $675.1M | +46.1% |
| Current Assets | $1.17B | +28.1% |
| Total Assets | $1.47B | +27.0% |
| Current Liabilities | $710.9M | +149.6% |
| Long-term Debt | $250.0M | -64.7% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $640.0M | +18.2% |
| Capital Expenditures | $12.6M | +5.1% |
| Investing Cash Flow | -$12.6M | -5.1% |
| Financing Cash Flow | -$604.1M | -16.6% |
| Free Cash Flow | $627.4M | +18.5% |
| +103.4% |
| EPS (Basic) | $11.77 | +103.3% |
| EPS (Diluted) | $11.76 | +103.1% |
| Total Liabilities |
| $798.2M |
| -24.7% |
| Stockholders' Equity | $668.3M | +603.0% |